We are live on ! Find out more
Mass General Brigham

Mass General Brigham Portfolio holdings

AUM $456M Turnover 50%
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
-1.01%
1 Year Est. Return
+27.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$456M
AUM Growth
+$95.2M
Cap. Flow
+$100M
Cap. Flow %
21.98%
Top 10 Hldgs %
100%
Holding
10
New
4
Increased
1
Reduced
1
Closed
1
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
VT icon
Vanguard Total World Stock ETF
VT
+$301M
2
SPCX icon
SpaceX
SPCX
+$32.4M
3
LYNX
Lyntris
LYNX
+$25.9M
4
IOT icon
Samsara
IOT
+$1.52M
5
MAZE icon
Maze Therapeutics
MAZE
+$268K

Top Sells

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$198M
2
KRMN icon
Karman Holdings
KRMN
+$63.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 65.85%
2 Healthcare 19.42%
3 Industrials 14.4%
4 Technology 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VT icon
1
Vanguard Total World Stock ETF
VT
$80B
$300M 65.85%
+1,898,645
New +$301M
2026 Q3
0 quarters
RVMD icon
2
Revolution Medicines
RVMD
$34.6B
$70.6M 15.48%
344,091
– –
2024 Q1
10 quarters
SPCX icon
3
SpaceX
SPCX
$1.95T
$35.3M 7.74%
+234,140
New +$32.4M
2026 Q3
0 quarters
LYNX
4
Lyntris
LYNX
$1.48B
$23.6M 5.17%
+1,916,964
New +$25.9M
2026 Q3
0 quarters
TNGX icon
5
Tango Therapeutics
TNGX
$3.71B
$8.84M 1.94%
354,192
– –
2024 Q1
10 quarters
MAZE icon
6
Maze Therapeutics
MAZE
$1.71B
$6.79M 1.49%
249,636
+9,642
+4% +$268K
2025 Q4
3 quarters
KRMN icon
7
Karman Holdings
KRMN
$4.53B
$6.78M 1.49%
209,261
-1,352,793
-87% -$63.1M
2025 Q4
3 quarters
MDLN icon
8
Medline
MDLN
$34.4B
$2.37M 0.52%
68,413
– –
2025 Q4
3 quarters
IOT icon
9
Samsara
IOT
$23.4B
$1.52M 0.33%
+39,772
New +$1.52M
2026 Q3
0 quarters
ACWI icon
10
iShares MSCI ACWI ETF
ACWI
$31.5B
– –
-1,259,657
Closed -$198M –

Similar funds

Mass General Brigham's Q3 2026 Portfolio in Review

As of Q3 2026, Mass General Brigham held 10 positions worth $456M, up 26% from $361M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mass General Brigham deployed $100M of net new capital in Q3 2026, opening 4 new positions and adding to 1 existing holding. Its largest new stake was Vanguard Total World Stock ETF: 1,898,645 shares worth $300M.

By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, up from 55% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Karman Holdings, an estimated $63.1M trimmed.

  • Mass General Brigham's largest Q3 2026 buy was Vanguard Total World Stock ETF: 1,898,645 shares worth $300M.
  • Mass General Brigham added most to Maze Therapeutics in Q3 2026, an estimated $268K increase.
  • Mass General Brigham's biggest Q3 2026 reduction was Karman Holdings, cutting an estimated $63.1M.
  • Mass General Brigham fully exited iShares MSCI ACWI ETF in Q3 2026, selling an estimated $198M.
  • Mass General Brigham's ten largest holdings make up 100% of its $456M portfolio in Q3 2026.
  • Mass General Brigham opened 4 new positions and closed 1 in Q3 2026.
  • Mass General Brigham's portfolio value rose 26% quarter-over-quarter to $456M.

Based on Mass General Brigham's 13F filing for Q3 2026, filed 3 Nov 2026.